eJHaem

Wiley · United Kingdom · Est. 1887

eISSN2688-6146

✓ WOS ESCI✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Source: Clarivate Journal Citation Reports.

H-Indexi

Total Worksi

1,399

Total Citationsi

5,118

2yr Mean Citednessi

1.06

Open Impact Factor alternative

Aims & Scope

Subject areas: Hematology.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1887

StatusActive (last: 2026)

Total Publications1,399

Publisher OrgWiley

OA Since2019

Visit Journal Website

Submission Info

Peer ReviewAnonymous peer review

OA LicenseCC BY, CC BY-NC, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/11 · 73%

✅

Do you know the journal / publisher?

Wiley

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2688-6146

✅

Indexed in a trusted database?

WoS, DOAJ, PubMed

✅

Peer review process documented?

Anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Subject Classification

Web of Science Categories

Hematology

Research Topics (OpenAlex)

Lymphoma Diagnosis and TreatmentAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchMultiple Myeloma Research and TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentHemoglobinopathies and Related DisordersChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchCAR-T cell therapy researchBlood groups and transfusion

Frequently asked questions about eJHaem

Is eJHaem a predatory journal?

PubScope has no integrity flags on record for eJHaem: it is indexed in Web of Science, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of eJHaem?

eJHaem is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.06.

Is eJHaem indexed in Scopus and Web of Science?

eJHaem is indexed in Web of Science, DOAJ.

What is the aims and scope of eJHaem?